The travel and entry restrictions imposed across the world in response to the COVID-19 epidemic have caused unprecedented obstacles for global enterprises to manage their subsidiaries in China. Meanwhile, as industrial and commercial activities continue to recover in China, multinationals are facing renewed challenges how to streamline the administrative management of their businesses in China to benefit from the Foreign Investment Law and a number of implementing regulations coming into force on 1 January 2020, which are widely considered as a major step the Chinese authorities made to consolidate previously fragmented foreign investment laws.
Bird & Bird partner Dr. Sven-Michael Werner looks at relevant legal issues and countermeasures to navigate the difficult times in managing subsidiaries in China in the wake of the outbreak of COVID-19 epidemic as well as how to adapt your business to the administrative management mechanism in the new era of China's foreign investment regime.
|16:00 - 16:10 HKT||Opening Remarks|
|16:10 - 16:45 HKT||
|16:45 - 17:00 HKT||Q&A|